Drugs / Beriplex P/N
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02074358 | Feb → Apr 2014 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beriplex P/N | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02074358 ↗ |
| Modality | Protein / enzyme biologic | “Beriplex P/N (4-Factor PCC)” NCT02074358 ↗ |
| Route | Intravenous | “a Beriplex P/N (4-Factor PCC) 50 IU/kg infusion for 30 min Intravenously” NCT02074358 ↗ |